This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
Sign a petition asking policymakers to take action against Hep C by dropping discriminatory Medicaid restrictions on Hep C treatment.
The NYC Health Department has released its 2016 Hepatitis B and C Annual Report, and this past year amended the Health Code to improve complete hepatitis C diagnostic testing and outcomes in NYC.
Examining Hepatitis C Virus Treatment Access: A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
The NYC Health Department is proposing that the Board amend Health Code §13.03(b)(3)(A) to require laboratories to report all hepatitis B virus (Hep B) DNA test results, including negative results - please comment!
The NYS Department of Health has released new guidelines on screening, diagnosis, and treatment of chronic hepatitis C.
Watch and share this new video about prescription medication misuse and Hep C risk among young people in Staten Island.
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
Health Department Releases Report On Hepatitis Surveillance And Programs In New York City, Launches Ad Campaign To Promote New Health Care Services For People Living With Viral Hepatitis
The Centers for Medicare and Medicaid Services (CMS) made the final decision to cover screening for hepatitis B infection at no cost to individuals entitled to benefits under Medicare Part A or enrolled in Medicare Part B.
